ClinicalTrials.gov
public full text
Public Domain
Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial
A common long-term side effect of anti-rejection (immunosuppressant) medications is skin cancer. This pilot clinical trial evaluates the feasibility of conducting a larger pivotal trial to examine the efficacy and safety of nicotinamide for prevention of keratinocyte carcinoma in solid organ transplant recipients. This pilot trial will transition into the pivotal trial if all feasibility targets are met.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults#901663
- E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness#862451
- Effects of liquid nicotine concentration and flavour on the acceptability of electronic nicotine delivery systems (ENDS) among people who smoke participating in a randomised controlled trial to reduce cigarette consumption#419081
- Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer#899203
- Smoking Cessation Apps and Technology Acceptance Factors: Focusing on the Sense2Quit Application.#975799
Record · ID 833679
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive